Oneness Biotech Co., Ltd.

Oneness received Medical Devices Export License approvals by TFDA on Bonvadis Topical Cream and Bonvadis Cream. The certificate will be collected accordingly.

2023-03-22

Statement
No	1	Date of announcement	2023/03/22	Time of announcement	18:32:02
Subject	Oneness received Medical Devices Export License approvals by TFDA on Bonvadis Topical Cream and Bonvadis Cream. The certificate will be collected accordingly.
To which item it meets	paragraph 53			Date of events	2023/03/22
Date of occurrence of the event:2023/03/22 Company name:ONENESS BIOTECH CO., LTD. Relationship to the Company (please enter ”head office” or ”subsidiaries”):head office Reciprocal shareholding ratios:NA Cause of occurrence:The Medical Device Export Licenses approvals issued by the Taiwan Food and Drug Administration (TFDA) on Bonvadis Topical Cream (Wound management device) and Bonvadis Cream (Scar management device) had been received today under approval numbers in 001745 and 001746, respectively. Countermeasures:None. Any other matters that need to be specified(the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):None.

↑

關閉

建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。

要下載瀏覽器，請直接點擊以下:

IE瀏覽器現已不支援大多數網站，並將於2022年6月終止服務

如何使用IE找到Microsoft Edge?

開啟新分頁(紅色框)
於搜尋框中打入Edge(紅色框)，並按搜尋(藍色框)
點擊【立即啟動】(藍框處)打開 Microsoft Edge